Hyperhomocysteinemia is an established risk factor for atherosclerosis and vascular
disease. Until the early nineties the relationship with venous thrombosis was controversial …

Background Previous studies have suggested that hyperhomocysteinemia may be a risk
factor for venous thrombosis. To assess the risk of venous thrombosis associated with …

Background Elevated plasma homocysteine (Hcy) levels are implicated in the development
of atherosclerotic and venous thromboembolic disease. A meta-analysis of the risk for …

Increased risk of arterial and venous thromboembolic disease is well documented in the
homocystinuric patient. There is growing evidence that hyperhomocysteinemia is an …

Homocysteine is a sulfhydryl-containing amino acid formed during the metabolism of
methionine. Rapidly accumulating evidence links elevated homocysteine levels to …

Evidence of a positive association between mild hyperhomocysteinemia and arterial
vascular disease has been accumulating in the last decade. Mild hyperhomocysteinemia …

Hyperhomocysteinemia is a risk factor for atherosclerosis and thrombosis and is inversely
related to plasma folate and vitamin B12 levels. We assessed the effects of vitamin …

Homocysteine (Hcy) is a sulfhydryl amino acid derived from the metabolic conversion of
methionine, which is dependent on vitamins (folic acid, B 12 and B 6) as cofactors or …

High plasma levels of homocysteine are the results of the interplay between congenital and
environmental factors. In the last two decades, a growing amount of interest has focused on …

Abstract The Vitamins and Thrombosis (VITRO) study investigated the effect of
homocysteine lowering by daily supplementation of B vitamins on the risk reduction of deep …